April 21, 2014 6:21 AM ET

Capital Markets

Company Overview of Colony Capital, LLC

Executive Profile

Richard D. Nanula

Former Chief Financial Officer, Executive Vice President of Finance and Executive Vice President of Strategy & Communications, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 8 different industries.

See Board Relationships
52--

Background

Mr. Richard D. Nanula serves as Chairman of LodgeNet Interactive Corporation. He was a Principal at Colony Capital, LLC. Mr. Nanula joined Colony Capital on January 8, 2008. Mr. Nanula was an Executive Vice President, Finance, Strategy, & Communications at Amgen Inc. At Amgen, he was the Executive Vice President since May 2001 and the Chief Financial Officer since August 2001. He joined Amgen in 2001. From November 1999 to February 2001, Mr. Nanula served as the Chairman ...

Corporate Headquarters

2450 Broadway
Santa Monica, California 90404

United States

Phone: 310-282-8820
Fax: 310-282-8808

Board Members Memberships

Director
Chairman
Trustee
Chairman
Board Member
1999-N/A
Former Chairman of the Board and Chief Executive Officer
2005-2007
Former Independent Director, Member of Audit Committee, Member of Special Programs Committee and Member of Finance Committee

Education

MBA 1986
Harvard University
BA 1982
University of California, Santa Barbara

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer and Member of the Senior Management Board
Novo Nordisk A/S
$11.3M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.0M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Colony Capital, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.